Cancer Research

For decades, digoxin has been one of the most polarizing medications in the cardiology toolkit. Derived originally from the foxglove plant, the drug is prized for … Read more

For many patients, surviving a myocardial infarction—a heart attack—is only the first hurdle. The real challenge often begins in the weeks that follow, as the heart … Read more

In the crowded waiting rooms of rural health clinics across Sub-Saharan Africa and Southeast Asia, the “clinical eye” has long been the primary tool for survival. … Read more

For millions of people, a routine primary care visit often culminates in a high-stakes calculation. A physician plugs age, blood pressure, and cholesterol levels into a … Read more

For many individuals of African ancestry, a specific genetic blueprint can signal a heightened risk of kidney failure. The APOL1 gene, when carrying high-risk variants, has … Read more

For individuals living with advanced retinitis pigmentosa, the world often shrinks into a narrow tunnel of vision before fading into near-total darkness. This genetic degeneration destroys … Read more

For patients facing metastatic pancreatic ductal adenocarcinoma (mPDAC), the clinical landscape has long been defined by limited options and sobering prognoses. Although, new data from a … Read more

In the quiet corridors of a hospital, the most dangerous moments are often the ones that happen silently. A patient’s blood pressure dips slightly, their respiratory … Read more

For decades, the medical community has tracked the menstrual cycle primarily through the lens of a few key hormones, such as estradiol and progesterone. Although, a … Read more